Basile C, Addabbo G, Montanaro A
Nephrology Unit, General Hospital, Martina Franca, Italy.
J Nephrol. 2001 Sep-Oct;14(5):420-3.
The pathogenesis of anterior ischemic optic neuropathy (AION) primarily involves interference with the posterior ciliary artery blood supply to the prelaminar optic nerve. Uremic patients often have coexisting pathology such as hypotension (decreased blood delivery), or hypertension, atherosclerosis (increased resistance to blood supply), and anemia (low blood oxygen carrying capacity), predisposing them to AION. We describe a 49-year-old patient on dialysis for many years. He had long-standing hypotension, worsened during each dialysis treatment. He awoke one morning at age 48 complaining of blurred vision in the left inferior field. Based on the clinical course, funduscopic and fluorangiographic examination and visual field defects, AION was diagnosed. Nine months after the loss of vision in the left eye, vision in the right eye became blurred and worsened over the next 24 hours. The diagnosis of AION in the right eye was made. At the last examination ten months later, the patient, still amaurotic, was given a very poor prognosis for further recovery of the visual defects. Surprisingly, very few cases of AION have been reported in chronic uremic patients on dialysis: to the best of our knowledge, only 12 including ours. Most of these cases share some features, including hypotension above all and anemia as common risk factors. Neither the type of dialysis treatment (hemo-, peritoneal dialysis) nor sex seem to have any influence on the occurrence of AION. Uremic children can be affected. What is striking in the three published pediatric cases is that they all had polycystic kidney disease. Treatment of AION in all 12 cases consisted of a combination of steroids, i.v. saline, blood transfusions and rhEpo. AION was more frequently bilateral and irreversible, ending in permanent amaurosis. In conclusion, this study aims to stress that most cases of AION occurring in chronic uremic patients on dialysis have some common features, including hypotension above all and anemia as common risk factors.
前部缺血性视神经病变(AION)的发病机制主要涉及睫状后动脉对筛板前视神经血液供应的干扰。尿毒症患者常伴有诸如低血压(血液输送减少)、高血压、动脉粥样硬化(血液供应阻力增加)和贫血(血液携氧能力降低)等共存病症,使他们易患AION。我们描述了一位49岁接受多年透析治疗的患者。他长期存在低血压,每次透析治疗期间病情都会加重。48岁时的一天早晨,他醒来后诉说左下视野视力模糊。根据临床病程、眼底和荧光血管造影检查以及视野缺损情况,诊断为AION。左眼失明9个月后,右眼视力变得模糊,并在接下来的24小时内恶化。右眼也被诊断为AION。在10个月后的最后一次检查中,该患者仍然失明,其视力缺陷进一步恢复的预后非常差。令人惊讶的是,慢性透析尿毒症患者中报道的AION病例非常少:据我们所知,包括我们的病例在内仅有12例。这些病例大多有一些共同特征,其中最重要的是低血压和贫血是常见的危险因素。透析治疗类型(血液透析、腹膜透析)和性别似乎对AION的发生没有任何影响。尿毒症儿童也可能受到影响。已发表的3例儿科病例的显著特点是他们都患有多囊肾病。所有12例AION的治疗均包括类固醇、静脉注射生理盐水、输血和重组人促红细胞生成素的联合应用。AION更常为双侧且不可逆,最终导致永久性失明。总之,本研究旨在强调,慢性透析尿毒症患者中发生的大多数AION病例有一些共同特征,其中最重要的是低血压和贫血是常见的危险因素。